Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Accounts Payables: 2023-2024

Historic Accounts Payables for Upstream Bio (UPB) over the last 2 years, with Dec 2024 value amounting to $4.0 million.

  • Upstream Bio's Accounts Payables fell 19.33% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year decrease of 19.33%. This contributed to the annual value of $4.0 million for FY2024, which is 103.07% up from last year.
  • Latest data reveals that Upstream Bio reported Accounts Payables of $4.0 million as of FY2024, which was up 103.07% from $2.0 million recorded in FY2023.
  • Upstream Bio's 5-year Accounts Payables high stood at $4.0 million for FY2024, and its period low was $2.0 million during FY2023.
  • Its 2-year average for Accounts Payables is $3.0 million, with a median of $3.0 million in 2023.
  • Data for Upstream Bio's Accounts Payables shows a peak YoY skyrocketed of 103.07% (in 2024) over the last 5 years.
  • Upstream Bio's Accounts Payables (Yearly) stood at $2.0 million in 2023, then spiked by 103.07% to $4.0 million in 2024.